Legal & General Group Plc Invests $329.76 Million in Humana Inc. $HUM

Legal & General Group Plc acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 830,170 shares of the insurance provider’s stock, valued at approximately $329,760,000.

Several other institutional investors also recently bought and sold shares of the business. Wilkerson Advisory Group LLC raised its stake in Humana by 24.6% in the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after buying an additional 33 shares in the last quarter. Bogart Wealth LLC boosted its position in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Fiduciary Alliance LLC increased its holdings in shares of Humana by 0.9% in the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after acquiring an additional 49 shares during the period. Sanctuary Advisors LLC increased its holdings in shares of Humana by 1.6% in the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after acquiring an additional 52 shares during the period. Finally, Horizon Investments LLC raised its position in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after acquiring an additional 55 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Up 0.6%

Humana stock opened at $388.92 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market cap of $46.70 billion, a PE ratio of 36.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. The stock has a 50-day moving average of $383.88 and a two-hundred day moving average of $285.00. Humana Inc. has a one year low of $163.11 and a one year high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the firm earned $6.27 earnings per share. The company’s revenue was up 26.2% on a year-over-year basis. On average, research analysts anticipate that Humana Inc. will post 9.12 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently weighed in on HUM. Robert W. Baird set a $390.00 price objective on Humana in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft started coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating for the company. Zacks Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Cantor Fitzgerald lifted their price objective on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 7th. Finally, TD Cowen boosted their price objective on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $403.91.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.